CLINICAL_TRIALS ClinicalTrials.gov record update

Receptivity of Endometrial Tissue and Peripheral Blood Mononuclear Cells in the Pathogenetic Rationale for the Management of Postmenopause Patients With Endometrial Proliferative Processes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06115577
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:28.673699+00:00
Published At: 2023-11-15T00:00:00+00:00
Record Updated At: 2023-11-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Endometrial Hyperplasia Without Atypia", "Endometrial Hyperplasia With Atypia", "Endometrial Cancer", "Peripheral Blood Mononuclear Cells", "Postmenopause", "Estrogen Receptor", "Progesterone Receptor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-11-15"
protocolSection.identificationModule.nctId: "NCT06115577"
protocolSection.identificationModule.officialTitle: "Receptivity of Endometrial Tissue and Peripheral Blood Mononuclear Cells in the Pathogenetic Rationale for the Management of Postmenopause Patients With Endometrial Proliferative Processes"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.